PT-141 (Bremelanotide)
1025.2 Da
Liquid
~2.7 hours
Refrigerate at 2–8°C, protect from light
// PAI-2026-05
PT-141 (Bremelanotide) is a synthetic analogue of α-MSH that acts on melanocortin receptors in the central nervous system. Unlike PDE5 inhibitors, it works centrally via hypothalamic pathways to enhance sexual arousal and function in both men and women. It has been studied extensively for hypoactive sexual desire disorder and erectile dysfunction.
Select Quantity
10 mg · Lyophilized
$158.44
per mg
$15.84
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Liquid formulation — ready to use
Batch PAI-2026-05 · Issued Jul 27, 2026
99.5%
RP-HPLC · UV 220nm
Confirmed
LC-MS/MS · ESI+
<0.1 EU/mg
LAL method
<10 CFU/g
USP <61>
HPLC Purity Profile
99.5% main peak| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Purity (HPLC) | RP-HPLC | ≥98.0% | 99.5% | PASS |
| Identity (MS) | LC-MS/MS | Conforms | Conforms | PASS |
| Appearance | Visual | White powder | Conforms | PASS |
| Moisture | Karl Fischer | ≤8.0% | 4.5% | PASS |
| Residual Solvents | GC-HS | ICH Q3C | Conforms | PASS |
| Endotoxins | LAL | <1 EU/mg | <0.1 EU/mg | PASS |
Testing performed by independent ISO-accredited laboratory. Full chromatograms and spectra available in the downloadable COA document.
Bremelanotide for hypoactive sexual desire disorder
J Sex Med · 2019
For research purposes only. These references are provided for informational use and do not constitute medical advice.
≥99.5% purity · 3367.9 Da
Long-acting GHRH analogue that stimulates sustained growth hormone release. Studied for body composition, recovery, and anti-aging.
≥99.5% purity · —
Synergistic GHRH + GHS combination for amplified, pulsatile growth hormone release. The gold standard GH peptide stack.
≥99.5% purity · 7649.1 Da
Potent anabolic growth factor mediating many effects of GH. Studied for muscle growth, recovery, neuroprotection, and metabolic health.